Stay updated on Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 appears in the page footer. No substantive changes to the study content or layout are detected.
    Difference
    0.1%
    Check dated 2026-01-15T04:31:02.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a Locations section listing New York and Ohio as study sites; this consolidates the prior New York Locations and Ohio Locations entries. The page revision was updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed from the footer.
    Difference
    0.3%
    Check dated 2025-12-24T13:47:31.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2. No visible changes to the study details or page behavior.
    Difference
    0.1%
    Check dated 2025-11-25T14:43:24.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The funding-status banner regarding government operations has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:28:22.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The screenshots indicate only minor UI/layout updates with no changes to core study content (title, objectives, eligibility, endpoints, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:56:31.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    3%
    Check dated 2025-10-06T08:12:23.000Z thumbnail image

Stay in the know with updates to Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.